Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

American Journal of Human Genetics

Volumn 67, Issue 4, 2000, Pages 841-850

  Unger, Meredith A ^a,b   Nathanson, Katherine L ^a,b   Calzone, Kathleen ^a,b   Antin Ozerkis, Danielle ^a,b   Shih, Helen A ^a,b   Martin, Anne Marie ^a,b   Lenoir, Gilbert M ^a,b   Mazoyer, Sylvie ^a,b   Weber, Barbara L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ARTICLE; BREAST CANCER; CANCER SCREENING; CARCINOGENESIS; EXON; FAMILY STUDY; GEL ELECTROPHORESIS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

EID: 0033799478     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/303076     Document Type: Article

References (28)

1. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations
2. The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21
3. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: Further evidence implicating Alu sequences in the chromosome translocation
4. Genomic sequencing
5. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
6. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
7. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families
8. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: No evidence for other ovarian cancer-susceptibility genes
9. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: Evidence for phenotypic differencesin cases with and without identified mutation
10. Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains
11. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
12. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families
13. High frequency of large intragenic deletions in the Fanconi anemia group A gene
14. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
15. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families
16. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family
17. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families
18. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
19. An Alu-mediated duplication in the BRCA1 gene: A new founder mutation?
20. Screening for genomic rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions
21. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17
22. An Alu-mediated 7.1 kb deletion of BRCA1 exons in 8 and 9 in breast and ovarian cancer families that results in alternate splicing of exon 10
23. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1
24. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
25. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family
26. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis
27. Conversion of diploidy to haploidy